Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND AND AIMS: Sorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), yet treatment safety may be challenged by portal hypertension. We therefore assessed the prevalence, risk factors and clinical consequences of esophageal varices (EVs) in sorafenib-treat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:United European Gastroenterol J
Asıl Yazarlar: Iavarone, Massimo, Primignani, Massimo, Vavassori, Sara, Sangiovanni, Angelo, La Mura, Vincenzo, Romeo, Raffaella, Colombo, Massimo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2015
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924436/
https://ncbi.nlm.nih.gov/pubmed/27403302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615615041
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller